Publications by authors named "Guy Goodwin"

Claim this Profile
C
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Robin Carhart-Harris, Jamie Chai-Rees

J Affect Disord· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.
Namik Kirlić, Merve Atli, Sunil Mistry, Michael Gold, Guy M Goodwin

J Clin Psychopharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.
Niall M McGowan, James J Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Guy M Goodwin

J Psychopharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
Robert F Dougherty, Patrick Clarke, Merve Atli, Joanna Kuc, Danielle Schlosser, Guy M Goodwin

Psychopharmacology (Berl)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-mental health inpatient and emergency care hospital costs associated with four mental disorders in Europe: a modelling study.
Dennis Wienand, Guy M Goodwin, Judit Simon

Lancet Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose of lamotrigine induces a positive memory bias in healthy volunteers.
Tarek Zghoul, Pilar Artiach Hortelano, Alexander Kaltenboeck, Lucy Wright, Guy M Goodwin

Psychol Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Robin Carhart-Harris, Jamie Chai-Rees

J Affect Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
Guy M Goodwin, Ania Nowakowska, Merve Atli, Boadie W Dunlop, David Feifel

J Clin Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.
Namik Kirlić, Molly Lennard-Jones, Merve Atli, Ekaterina Malievskaia, Nadav L Modlin, Guy M Goodwin

Am J Psychiatry· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.
Lindsey Marwood, Megan Croal, Sunil Mistry, Hollie Simmons, Joyce Tsai, Guy M Goodwin

J Psychiatr Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the incidence of inadequate response to antidepressants in the primary care of depression.
Abigail B Abrahams, Amy C Beckenstrom, Michael Browning, Rebecca Dias, Guy M Goodwin

Eur Neuropsychopharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypersexuality in bipolar disorder: an overlooked symptom.
Clare Dolman, Louise Howard, Guy M Goodwin, Allan Young, Ian R Jones

Lancet Psychiatry· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
Giuseppe Pasculli, Pierpaolo Busan, Eric S Jackson, Per A Alm, Danilo De Gregorio, Guy M Goodwin

Front Hum Neurosci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbid physical health burden of serious mental health disorders in 32 European countries.
Dennis Wienand, Lena I Wijnen, Daniel Heilig, Christoph Wippel, Celso Arango, Guy M Goodwin

BMJ Ment Health· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Must Psilocybin Always "Assist Psychotherapy"?
Guy M Goodwin, Ekaterina Malievskaia, Gregory A Fonzo, Charles B Nemeroff

Am J Psychiatry· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.
Guy M Goodwin, Ekaterina Malievskaia, Gregory A Fonzo, Charles B Nemeroff

Am J Psychiatry· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.
Drummond E-Wen McCulloch, Matthias E Liechti, Kim Pc Kuypers, David Nutt, Johan Lundberg, Guy M Goodwin

Neurosci Appl· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial.
Nils Inge Landrø, Catherine J Harmer, Simon E Blackwell, Ragnhild Bø, Gerry Dawson, Guy Goodwin

Contemp Clin Trials· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The psychedelic experience and treatment-resistant depression.
Guy M Goodwin

World Psychiatry· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
Guy M Goodwin, Megan Croal, David Feifel, John R Kelly, Lindsey Marwood

Neuropsychopharmacology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing intrusive memories after trauma via an imagery-competing task intervention in COVID-19 intensive care staff: a randomised controlled trial.
Lalitha Iyadurai, Julie Highfield, Marie Kanstrup, Alfred Markham, Varsha Ramineni, Guy M Goodwin

Transl Psychiatry· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression.
Sameer Jauhar, Danilo Arnone, David S Baldwin, Michael Bloomfield, Michael Browning, Guy M Goodwin

Mol Psychiatry· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder.
Craig Steel, Kim Wright, Guy M Goodwin, Judit Simon, Nicola Morant

Int J Bipolar Disord· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unblinding and demand characteristics in the treatment of depression.
Guy M Goodwin, Megan Croal, Lindsey Marwood, Ekaterina Malievskaia

J Affect Disord· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psilocybin for Treatment-Resistant Depression. Reply.
Guy M Goodwin, David J Hellerstein, Allan H Young

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis